Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cefaclor (Sam-A Pharm)
- Development stage
- Unknown
- Lead developer
- Sam-A Pharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cefaclor is a second-generation cephalosporin antibiotic used to treat various bacterial infections, particularly those of the respiratory tract, such as pneumonia, bronchitis, and tonsillitis. Sam-A Pharmaceutical developed a sustained-release formulation of cefaclor using its proprietary IDIA™ (Intelligent Drug Interaction & Absorption) controlled-release microparticle technology. This formulation allows for a twice-daily dosing regimen, improving patient compliance compared to the standard thrice-daily dosing of immediate-release cefaclor. The drug exerts its antibacterial effect by binding to and inhibiting penicillin-binding proteins (PBPs) involved in bacterial cell wall synthesis, leading to cell lysis and death.
- Brand names
- Cefclor SRCefclor MR
- Other names
- cefaclor sustained-releasecefaclor extended-release
02
Targets
PBP (Penicillin-binding protein family)
Beyond the preview
Go deeper on cefaclor (Sam-A Pharm).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cefaclor (Sam-A Pharm).